“十四五”以来 医保基金累计支出12.13万亿元 年均增速9.1%

Group 1 - The core viewpoint of the news is the emphasis on the dual role of medical insurance as both a financial support system and a service provider, highlighting its contributions to the healthcare industry and economic development [1][2] - The National Medical Insurance Bureau has established a prepayment system for medical insurance funds and has implemented real-time settlement reforms, covering 357 regions and disbursing 594.8 billion yuan since 2025 [2] - The medical insurance fund has cumulatively spent 12.13 trillion yuan since the beginning of the 14th Five-Year Plan, with an annual growth rate of 9.1%, significantly supporting both patient reimbursements and the pharmaceutical industry [3] Group 2 - The medical insurance system is promoting reforms and openness, including the implementation of centralized drug procurement reforms and the establishment of a new directory for innovative drugs under commercial health insurance [4] - The National Medical Insurance Bureau is actively supporting the development of traditional Chinese medicine while also fostering innovation in medical technologies, such as artificial hearts and brain-machine interfaces [5] - Future initiatives will focus on effectively managing medical insurance funds to enhance the efficiency, safety, and accessibility of medical products and services, contributing to the overall health of the population [5]